[English] 日本語
Yorodumi
- PDB-7wc0: Crystal structure of Fab region of TAU-2212 neutralizing SARS-CoV-2 -

+
Open data


ID or keywords:

Loading...

-
Basic information

Entry
Database: PDB / ID: 7wc0
TitleCrystal structure of Fab region of TAU-2212 neutralizing SARS-CoV-2
Components
  • TAU-2212 Heavy chain
  • TAU-2212 Light chain
KeywordsIMMUNE SYSTEM
Biological speciesHomo sapiens (human)
MethodX-RAY DIFFRACTION / SYNCHROTRON / MOLECULAR REPLACEMENT / Resolution: 2.705 Å
AuthorsXiang, Y. / Li, R. / Ma, B.
Funding support1items
OrganizationGrant numberCountry
National Natural Science Foundation of China (NSFC)
CitationJournal: Commun Biol / Year: 2022
Title: Conformational flexibility in neutralization of SARS-CoV-2 by naturally elicited anti-SARS-CoV-2 antibodies.
Authors: Ruofan Li / Michael Mor / Bingting Ma / Alex E Clark / Joel Alter / Michal Werbner / Jamie Casey Lee / Sandra L Leibel / Aaron F Carlin / Moshe Dessau / Meital Gal-Tanamy / Ben A Croker / Ye ...Authors: Ruofan Li / Michael Mor / Bingting Ma / Alex E Clark / Joel Alter / Michal Werbner / Jamie Casey Lee / Sandra L Leibel / Aaron F Carlin / Moshe Dessau / Meital Gal-Tanamy / Ben A Croker / Ye Xiang / Natalia T Freund /
Abstract: As new variants of SARS-CoV-2 continue to emerge, it is important to assess the cross-neutralizing capabilities of antibodies naturally elicited during wild type SARS-CoV-2 infection. In the present ...As new variants of SARS-CoV-2 continue to emerge, it is important to assess the cross-neutralizing capabilities of antibodies naturally elicited during wild type SARS-CoV-2 infection. In the present study, we evaluate the activity of nine anti-SARS-CoV-2 monoclonal antibodies (mAbs), previously isolated from convalescent donors infected with the Wuhan-Hu-1 strain, against the SARS-CoV-2 variants of concern (VOC) Alpha, Beta, Gamma, Delta and Omicron. By testing an array of mutated spike receptor binding domain (RBD) proteins, cell-expressed spike proteins from VOCs, and neutralization of SARS-CoV-2 VOCs as pseudoviruses, or as the authentic viruses in culture, we show that mAbs directed against the ACE2 binding site (ACE2bs) are more sensitive to viral evolution compared to anti-RBD non-ACE2bs mAbs, two of which retain their potency against all VOCs tested. At the second part of our study, we reveal the neutralization mechanisms at high molecular resolution of two anti-SARS-CoV-2 neutralizing mAbs by structural characterization. We solve the structures of the Delta-neutralizing ACE2bs mAb TAU-2303 with the SARS-CoV-2 spike trimer and RBD at 4.5 Å and 2.42 Å resolutions, respectively, revealing a similar mode of binding to that between the RBD and ACE2. Furthermore, we provide five additional structures (at resolutions of 4.7 Å, 7.3 Å, 6.4 Å, 3.3 Å, and 6.1 Å) of a second antibody, TAU-2212, complexed with the SARS-CoV-2 spike trimer. TAU-2212 binds an exclusively quaternary epitope, and exhibits a unique, flexible mode of neutralization that involves transitioning between five different conformations, with both arms of the antibody recruited for cross linking intra- and inter-spike RBD subunits. Our study provides additional mechanistic understanding about how antibodies neutralize SARS-CoV-2 and its emerging variants and provides insights on the likelihood of reinfections.
History
DepositionDec 17, 2021Deposition site: PDBJ / Processing site: PDBJ
Revision 1.0Aug 10, 2022Provider: repository / Type: Initial release
Revision 1.1Sep 28, 2022Group: Database references / Category: citation / citation_author
Item: _citation.country / _citation.journal_abbrev ..._citation.country / _citation.journal_abbrev / _citation.journal_id_CSD / _citation.journal_id_ISSN / _citation.journal_volume / _citation.page_first / _citation.page_last / _citation.pdbx_database_id_DOI / _citation.pdbx_database_id_PubMed / _citation.title / _citation.year
Revision 1.2Nov 29, 2023Group: Data collection / Refinement description
Category: chem_comp_atom / chem_comp_bond ...chem_comp_atom / chem_comp_bond / pdbx_initial_refinement_model / struct_ncs_dom_lim
Item: _struct_ncs_dom_lim.beg_auth_comp_id / _struct_ncs_dom_lim.beg_label_asym_id ..._struct_ncs_dom_lim.beg_auth_comp_id / _struct_ncs_dom_lim.beg_label_asym_id / _struct_ncs_dom_lim.beg_label_comp_id / _struct_ncs_dom_lim.beg_label_seq_id / _struct_ncs_dom_lim.end_auth_comp_id / _struct_ncs_dom_lim.end_label_asym_id / _struct_ncs_dom_lim.end_label_comp_id / _struct_ncs_dom_lim.end_label_seq_id

-
Structure visualization

Structure viewerMolecule:
MolmilJmol/JSmol

Downloads & links

-
Assembly

Deposited unit
H: TAU-2212 Heavy chain
L: TAU-2212 Light chain
A: TAU-2212 Heavy chain
B: TAU-2212 Light chain


Theoretical massNumber of molelcules
Total (without water)103,9604
Polymers103,9604
Non-polymers00
Water5,999333
1
H: TAU-2212 Heavy chain
L: TAU-2212 Light chain


Theoretical massNumber of molelcules
Total (without water)51,9802
Polymers51,9802
Non-polymers00
Water362
TypeNameSymmetry operationNumber
identity operation1_555x,y,z1
Buried area2970 Å2
ΔGint-27 kcal/mol
Surface area20130 Å2
MethodPISA
2
A: TAU-2212 Heavy chain
B: TAU-2212 Light chain


Theoretical massNumber of molelcules
Total (without water)51,9802
Polymers51,9802
Non-polymers00
Water362
TypeNameSymmetry operationNumber
identity operation1_555x,y,z1
Buried area3210 Å2
ΔGint-25 kcal/mol
Surface area19620 Å2
MethodPISA
Unit cell
Length a, b, c (Å)75.977, 75.977, 348.140
Angle α, β, γ (deg.)90.000, 90.000, 120.000
Int Tables number170
Space group name H-MP65
Symmetry operation#1: x,y,z
#2: x-y,x,z+5/6
#3: y,-x+y,z+1/6
#4: -y,x-y,z+2/3
#5: -x+y,-x,z+1/3
#6: -x,-y,z+1/2
Noncrystallographic symmetry (NCS)NCS domain:
IDEns-IDDetails
11H
21A
32L
42B

NCS domain segments:
Dom-IDComponent-IDEns-IDBeg auth comp-IDBeg label comp-IDEnd auth comp-IDEnd label comp-IDAuth asym-IDLabel asym-IDAuth seq-IDLabel seq-ID
111VALVALLYSLYSHA2 - 22221 - 241
221VALVALLYSLYSAC2 - 22221 - 241
332ALAALAHISHISLB3 - 20322 - 222
442ALAALAHISHISBD3 - 20322 - 222

NCS ensembles :
IDDetails
1Local NCS retraints between domains: 1 2
2Local NCS retraints between domains: 3 4

-
Components

#1: Protein TAU-2212 Heavy chain


Mass: 27087.492 Da / Num. of mol.: 2
Source method: isolated from a genetically manipulated source
Source: (gene. exp.) Homo sapiens (human) / Production host: Homo sapiens (human)
#2: Antibody TAU-2212 Light chain


Mass: 24892.707 Da / Num. of mol.: 2
Source method: isolated from a genetically manipulated source
Source: (gene. exp.) Homo sapiens (human) / Production host: Homo sapiens (human)
#3: Water ChemComp-HOH / water


Mass: 18.015 Da / Num. of mol.: 333 / Source method: isolated from a natural source / Formula: H2O

-
Experimental details

-
Experiment

ExperimentMethod: X-RAY DIFFRACTION / Number of used crystals: 1

-
Sample preparation

CrystalDensity Matthews: 2.79 Å3/Da / Density % sol: 55.92 %
Crystal growTemperature: 309 K / Method: vapor diffusion, hanging drop / pH: 8
Details: 26% (w/v) polyethylene glycol 3350, 0.2 M (NH4)2SO4, pH 8.0

-
Data collection

DiffractionMean temperature: 100 K / Serial crystal experiment: N
Diffraction sourceSource: SYNCHROTRON / Site: SSRF / Beamline: BL02U1 / Wavelength: 0.98 Å
DetectorType: DECTRIS EIGER2 S 9M / Detector: PIXEL / Date: Sep 26, 2021
RadiationProtocol: SINGLE WAVELENGTH / Monochromatic (M) / Laue (L): M / Scattering type: x-ray
Radiation wavelengthWavelength: 0.98 Å / Relative weight: 1
Reflection twin
Crystal-IDIDOperatorDomain-IDFraction
11H, K, L10.603
11-K, -H, -L20.397
ReflectionResolution: 2.7→30 Å / Num. obs: 30854 / % possible obs: 100 % / Redundancy: 14.6 % / Rmerge(I) obs: 0.137 / Rpim(I) all: 0.037 / Rrim(I) all: 0.142 / Χ2: 1.827 / Net I/σ(I): 7.7 / Num. measured all: 450999
Reflection shell

Diffraction-ID: 1

Resolution (Å)Redundancy (%)Rmerge(I) obsNum. unique obsCC1/2Rpim(I) allRrim(I) allΧ2% possible all
2.7-2.7514.10.90415320.9160.2430.9370.526100
2.75-2.8150.80415450.9260.2120.8320.556100
2.8-2.8515.70.72315170.9450.1870.7470.575100
2.85-2.9115.80.60415780.9690.1560.6240.623100
2.91-2.9715.70.50915060.9750.1320.5260.658100
2.97-3.0415.60.45515590.9730.1180.470.772100
3.04-3.1215.20.38215110.9810.1010.3950.848100
3.12-3.214.10.33815530.9810.0930.3510.923100
3.2-3.2914.20.26815690.9850.0730.2781.173100
3.29-3.415.10.2415160.9880.0640.2491.424100
3.4-3.5213.90.20915250.9860.0580.2171.779100
3.52-3.6614.20.18315420.9950.050.192.031100
3.66-3.8315.20.16215390.9950.0440.1682.231100
3.83-4.0314.50.14615460.9930.040.1512.633100
4.03-4.2813.90.11515420.9960.0330.1193.04499.9
4.28-4.6113.50.09815310.9950.0280.1023.32100
4.61-5.0712.90.09415720.9960.0280.0983.57100
5.07-5.813.20.09115380.9980.0270.0953.54299.9
5.8-7.314.10.08215550.9970.0230.0853.386100
7.3-3016.50.06115780.9990.0150.0633.58799.9

-
Processing

Software
NameVersionClassification
REFMAC5.8.0267refinement
HKL-2000721.4data scaling
PDB_EXTRACTdata extraction
PHASERphasing
Cootmodel building
HKL-2000data scaling
HKL-2000data reduction
RefinementMethod to determine structure: MOLECULAR REPLACEMENT
Starting model: 7K8Q
Resolution: 2.705→29.746 Å / Cor.coef. Fo:Fc: 0.939 / Cor.coef. Fo:Fc free: 0.919 / SU B: 21.066 / SU ML: 0.336 / Cross valid method: THROUGHOUT / ESU R: 0.184 / ESU R Free: 0.068
Details: Hydrogens have been used if present in the input file
RfactorNum. reflection% reflectionSelection details
Rfree0.2462 1554 5.052 %RANDOM
Rwork0.2015 29204 --
all0.204 ---
obs-30758 99.673 %-
Solvent computationIon probe radii: 0.8 Å / Shrinkage radii: 0.8 Å / VDW probe radii: 1.2 Å / Solvent model: MASK BULK SOLVENT
Displacement parametersBiso mean: 93.79 Å2
Baniso -1Baniso -2Baniso -3
1-2.446 Å20 Å20 Å2
2--2.446 Å20 Å2
3----4.893 Å2
Refinement stepCycle: LAST / Resolution: 2.705→29.746 Å
ProteinNucleic acidLigandSolventTotal
Num. atoms6293 0 0 333 6626
Refine LS restraints
Refine-IDTypeDev idealDev ideal targetNumber
X-RAY DIFFRACTIONr_bond_refined_d0.0080.0126466
X-RAY DIFFRACTIONr_angle_refined_deg0.9691.6368827
X-RAY DIFFRACTIONr_dihedral_angle_1_deg8.4635829
X-RAY DIFFRACTIONr_dihedral_angle_2_deg35.08723.227251
X-RAY DIFFRACTIONr_dihedral_angle_3_deg20.88415977
X-RAY DIFFRACTIONr_dihedral_angle_4_deg19.0811517
X-RAY DIFFRACTIONr_chiral_restr0.0550.2859
X-RAY DIFFRACTIONr_gen_planes_refined0.0190.024869
X-RAY DIFFRACTIONr_nbd_refined0.2650.22841
X-RAY DIFFRACTIONr_nbtor_refined0.3030.24207
X-RAY DIFFRACTIONr_xyhbond_nbd_refined0.2490.2348
X-RAY DIFFRACTIONr_symmetry_nbd_refined0.3070.255
X-RAY DIFFRACTIONr_symmetry_xyhbond_nbd_refined0.3570.210
X-RAY DIFFRACTIONr_mcbond_it4.2825.4453337
X-RAY DIFFRACTIONr_mcangle_it6.3798.1574159
X-RAY DIFFRACTIONr_scbond_it4.0845.5493129
X-RAY DIFFRACTIONr_scangle_it6.0278.2254668
X-RAY DIFFRACTIONr_lrange_it11.351101.64325289
X-RAY DIFFRACTIONr_ncsr_local_group_10.1920.055240
X-RAY DIFFRACTIONr_ncsr_local_group_20.2070.054938
Refine LS restraints NCS
Ens-IDDom-IDAuth asym-IDRefine-IDTypeRms dev position (Å)Weight position
11HX-RAY DIFFRACTIONLocal ncs0.191730.05007
12AX-RAY DIFFRACTIONLocal ncs0.191730.05007
23LX-RAY DIFFRACTIONLocal ncs0.20710.05007
24BX-RAY DIFFRACTIONLocal ncs0.20710.05007
LS refinement shell
Resolution (Å)Rfactor RfreeNum. reflection RfreeRfactor RworkNum. reflection RworkRefine-ID% reflection obs (%)
2.705-2.7750.3261120.2512039X-RAY DIFFRACTION96.6307
2.775-2.8510.3451160.2712123X-RAY DIFFRACTION100
2.851-2.9330.2961120.2652086X-RAY DIFFRACTION100
2.933-3.0240.3191000.2351966X-RAY DIFFRACTION100
3.024-3.1220.2831090.2311929X-RAY DIFFRACTION100
3.122-3.2320.3511050.2431854X-RAY DIFFRACTION100
3.232-3.3540.3131030.2281808X-RAY DIFFRACTION100
3.354-3.490.336920.2311722X-RAY DIFFRACTION100
3.49-3.6450.225980.2111679X-RAY DIFFRACTION100
3.645-3.8220.248630.1991590X-RAY DIFFRACTION100
3.822-4.0280.298950.1921523X-RAY DIFFRACTION100
4.028-4.2710.184850.1851416X-RAY DIFFRACTION100
4.271-4.5650.229630.1741354X-RAY DIFFRACTION100
4.565-4.9290.158540.1631246X-RAY DIFFRACTION100
4.929-5.3960.197490.1741187X-RAY DIFFRACTION100
5.396-6.0280.212480.1931040X-RAY DIFFRACTION100
6.028-6.9510.261420.223949X-RAY DIFFRACTION100
6.951-8.4890.215470.194776X-RAY DIFFRACTION100
8.489-11.9070.163440.151593X-RAY DIFFRACTION100
11.907-29.7460.316170.206324X-RAY DIFFRACTION92.9155
Refinement TLS params.

Method: refined / Refine-ID: X-RAY DIFFRACTION

IDL112)L122)L132)L222)L232)L332)S11 (Å °)S12 (Å °)S13 (Å °)S21 (Å °)S22 (Å °)S23 (Å °)S31 (Å °)S32 (Å °)S33 (Å °)T112)T122)T132)T222)T232)T332)Origin x (Å)Origin y (Å)Origin z (Å)
12.70240.0761-1.18432.04090.21541.18430.0391-0.091-0.0194-0.097-0.124-0.0756-0.04770.05330.08490.59590.07550.00110.54-0.03160.017656.203-27.353-17.119
21.84090.9188-0.39923.4318-0.16220.69280.00820.2618-0.2442-0.4283-0.09920.2520.0382-0.27490.09110.62310.0605-0.04540.5525-0.07430.108634.966-6.1522.553
31.83850.1545-0.41493.08260.77911.99080.0486-0.170.2256-0.0291-0.1349-0.0195-0.11990.0910.08640.54870.0490.04770.52780.03390.055259.467-29.43819.559
41.92471.0861-0.3033.2128-0.20560.73250.0389-0.18830.17720.2102-0.1016-0.0310.00090.20770.06280.63390.07160.02860.53770.01240.053688.039-39.0070.661
Refinement TLS group
IDRefine-IDRefine TLS-IDSelectionAuth asym-IDAuth seq-ID
1X-RAY DIFFRACTION1ALLH1 - 122
2X-RAY DIFFRACTION1ALLL3 - 110
3X-RAY DIFFRACTION2ALLH123 - 222
4X-RAY DIFFRACTION2ALLL111 - 212
5X-RAY DIFFRACTION3ALLA2 - 122
6X-RAY DIFFRACTION3ALLB2 - 110
7X-RAY DIFFRACTION4ALLA123 - 222
8X-RAY DIFFRACTION4ALLB111 - 204

+
About Yorodumi

-
News

-
Feb 9, 2022. New format data for meta-information of EMDB entries

New format data for meta-information of EMDB entries

  • Version 3 of the EMDB header file is now the official format.
  • The previous official version 1.9 will be removed from the archive.

Related info.:EMDB header

External links:wwPDB to switch to version 3 of the EMDB data model

-
Aug 12, 2020. Covid-19 info

Covid-19 info

URL: https://pdbjlvh1.pdbj.org/emnavi/covid19.php

New page: Covid-19 featured information page in EM Navigator.

Related info.:Covid-19 info / Mar 5, 2020. Novel coronavirus structure data

+
Mar 5, 2020. Novel coronavirus structure data

Novel coronavirus structure data

Related info.:Yorodumi Speices / Aug 12, 2020. Covid-19 info

External links:COVID-19 featured content - PDBj / Molecule of the Month (242):Coronavirus Proteases

+
Jan 31, 2019. EMDB accession codes are about to change! (news from PDBe EMDB page)

EMDB accession codes are about to change! (news from PDBe EMDB page)

  • The allocation of 4 digits for EMDB accession codes will soon come to an end. Whilst these codes will remain in use, new EMDB accession codes will include an additional digit and will expand incrementally as the available range of codes is exhausted. The current 4-digit format prefixed with “EMD-” (i.e. EMD-XXXX) will advance to a 5-digit format (i.e. EMD-XXXXX), and so on. It is currently estimated that the 4-digit codes will be depleted around Spring 2019, at which point the 5-digit format will come into force.
  • The EM Navigator/Yorodumi systems omit the EMD- prefix.

Related info.:Q: What is EMD? / ID/Accession-code notation in Yorodumi/EM Navigator

External links:EMDB Accession Codes are Changing Soon! / Contact to PDBj

+
Jul 12, 2017. Major update of PDB

Major update of PDB

  • wwPDB released updated PDB data conforming to the new PDBx/mmCIF dictionary.
  • This is a major update changing the version number from 4 to 5, and with Remediation, in which all the entries are updated.
  • In this update, many items about electron microscopy experimental information are reorganized (e.g. em_software).
  • Now, EM Navigator and Yorodumi are based on the updated data.

External links:wwPDB Remediation / Enriched Model Files Conforming to OneDep Data Standards Now Available in the PDB FTP Archive

-
Yorodumi

Thousand views of thousand structures

  • Yorodumi is a browser for structure data from EMDB, PDB, SASBDB, etc.
  • This page is also the successor to EM Navigator detail page, and also detail information page/front-end page for Omokage search.
  • The word "yorodu" (or yorozu) is an old Japanese word meaning "ten thousand". "mi" (miru) is to see.

Related info.:EMDB / PDB / SASBDB / Comparison of 3 databanks / Yorodumi Search / Aug 31, 2016. New EM Navigator & Yorodumi / Yorodumi Papers / Jmol/JSmol / Function and homology information / Changes in new EM Navigator and Yorodumi

Read more